Fulgent Genetics (FLGT) News Today $18.68 -0.14 (-0.74%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$18.64 -0.04 (-0.19%) As of 05/7/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Fulgent Genetics (NASDAQ:FLGT) Shares Gap Down - Should You Sell?Fulgent Genetics (NASDAQ:FLGT) Shares Gap Down - What's Next?May 7 at 12:28 PM | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Receives "Outperform" Rating from Raymond JamesRaymond James reiterated an "outperform" rating and issued a $25.00 target price (up from $24.00) on shares of Fulgent Genetics in a research note on Monday.May 7 at 10:00 AM | marketbeat.comRaymond James Reaffirms "Outperform" Rating for Fulgent Genetics (NASDAQ:FLGT)May 6 at 2:55 AM | americanbankingnews.comFulgent Genetics (NASDAQ:FLGT) Posts Earnings Results, Misses Expectations By $0.12 EPSFulgent Genetics (NASDAQ:FLGT - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.12). Fulgent Genetics had a negative return on equity of 1.81% and a negative net margin of 59.39%. The business had revenue of $73.46 million for the quarter, compared to analysts' expectations of $71.26 million. During the same quarter in the previous year, the firm posted ($0.01) EPS. Fulgent Genetics's revenue was up 14.0% on a year-over-year basis.May 5 at 8:47 AM | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Gap Up - Here's What HappenedFulgent Genetics (NASDAQ:FLGT) Shares Gap Up - Time to Buy?May 5 at 2:53 AM | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Releases FY 2025 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.650--0.65 for the period, compared to the consensus estimate of -0.660. The company also issued revenue guidance of $310.0 millionillion-$310.0 millionillion, compared to the consensus estimate of $310.4 millionillion.May 4, 2025 | marketbeat.comAlmitas Capital LLC Buys Shares of 16,000 Fulgent Genetics, Inc. (NASDAQ:FLGT)Almitas Capital LLC bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 16,000 shares of the company's stocMay 4, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Gap Up Following Strong EarningsMay 4, 2025 | americanbankingnews.comEarnings call transcript: Fulgent Genetics Q1 2025 beats EPS forecast, stock risesMay 3, 2025 | investing.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call TranscriptMay 3, 2025 | insidermonkey.comFulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathologyMay 2, 2025 | msn.comFulgent Genetics rises on earnings, revenue beatMay 2, 2025 | msn.comFulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comFulgent Reports First Quarter 2025 Financial ResultsMay 2, 2025 | businesswire.comPark West Asset Management LLC Lowers Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT)Park West Asset Management LLC lowered its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 10.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 641,682 shares of the company's stock after sellinMay 1, 2025 | marketbeat.comNebula Research & Development LLC Makes New $609,000 Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)Nebula Research & Development LLC acquired a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 32,960 shares of the company'May 1, 2025 | marketbeat.comFulgent Genetics (FLGT) Projected to Post Quarterly Earnings on FridayMay 1, 2025 | americanbankingnews.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by Invesco Ltd.Invesco Ltd. raised its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 181,714 shares of the company's stock after purchasing an additional 22,301 shares duriApril 29, 2025 | marketbeat.comSyon Capital LLC Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)Syon Capital LLC purchased a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 15,546 shares of the company's stock, valued at approximately $287,000. Syon Capital LLC owned 0.05% of FulgApril 28, 2025 | marketbeat.comJump Financial LLC Acquires Shares of 25,300 Fulgent Genetics, Inc. (NASDAQ:FLGT)Jump Financial LLC bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 25,300 shares of the company's stock, valued at approximately $467,000. JumApril 27, 2025 | marketbeat.comFulgent Genetics (FLGT) to Release Quarterly Earnings on FridayFulgent Genetics (NASDAQ:FLGT) will be releasing its Q1 2025 earnings before the market opens on Friday, May 2. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-2-fulgent-genetics-inc-stock/)April 27, 2025 | marketbeat.comFulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...April 21, 2025 | finance.yahoo.comJPMorgan Chase & Co. Has $8.70 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)JPMorgan Chase & Co. increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 39.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 471,259 shares of the company's stock after purchasing an addiApril 17, 2025 | marketbeat.comVanguard Group Inc. Has $25.69 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Vanguard Group Inc. reduced its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 4.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,391,074 shares of the company's stock after selling 57,597 shares duApril 16, 2025 | marketbeat.com37,088 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Purchased by Inlight Wealth Management LLCInlight Wealth Management LLC purchased a new stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 37,088 shares of the company's stock,April 13, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) shareholders have endured a 69% loss from investing in the stock three years agoApril 11, 2025 | finance.yahoo.comExodusPoint Capital Management LP Has $1.70 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)ExodusPoint Capital Management LP boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 75.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 92,197 shares of the company's stock after aApril 11, 2025 | marketbeat.comFulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025April 10, 2025 | businesswire.comTrexquant Investment LP Increases Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Trexquant Investment LP lifted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 47.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,606 shares of the cApril 9, 2025 | marketbeat.comShort Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Increases By 19.6%Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 1,650,000 shares, a growth of 19.6% from the February 28th total of 1,380,000 shares. Based on an average trading volume of 407,500 shares, the short-interest ratio is currently 4.0 days. Approximately 8.3% of the shares of the company are sold short.April 4, 2025 | marketbeat.comDiametric Capital LP Acquires New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Diametric Capital LP bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 38,818 shares of the company's stock, valApril 2, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $3.88 Million Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Charles Schwab Investment Management Inc. reduced its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 210,211 shares of the comMarch 27, 2025 | marketbeat.com22,238 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Acquired by Proficio Capital Partners LLCProficio Capital Partners LLC bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 22,238 shares of the company's stockMarch 25, 2025 | marketbeat.comMagnetar Financial LLC Purchases Shares of 16,977 Fulgent Genetics, Inc. (NASDAQ:FLGT)Magnetar Financial LLC purchased a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 16,977 shares of the company's stock, valued at aMarch 24, 2025 | marketbeat.comIntech Investment Management LLC Increases Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Intech Investment Management LLC boosted its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 248.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,539 shares of the company'sMarch 24, 2025 | marketbeat.comBank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)Bank of New York Mellon Corp cut its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 20.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,898 shares of tMarch 21, 2025 | marketbeat.comFulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A BuyMarch 20, 2025 | seekingalpha.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 803.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 125,957 shares of the company's stockMarch 19, 2025 | marketbeat.comAlphaQuest LLC Acquires 27,085 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)AlphaQuest LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 314.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,692 shares of the company's stMarch 12, 2025 | marketbeat.comProficio Capital Partners LLC Purchases New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Proficio Capital Partners LLC purchased a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 22,238 shares of the company's stock, valued at approximately $411,000. Proficio CapiMarch 11, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Sees Strong Trading Volume - Time to Buy?Fulgent Genetics (NASDAQ:FLGT) Sees Strong Trading Volume - What's Next?March 8, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying ActivityFulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying ActivityMarch 7, 2025 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Sees Large Growth in Short InterestFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 1,300,000 shares, a growth of 23.8% from the January 31st total of 1,050,000 shares. Approximately 6.5% of the company's stock are sold short. Based on an average trading volume of 255,400 shares, the short-interest ratio is presently 5.1 days.March 7, 2025 | marketbeat.comFulgent Genetics, Inc. (FLGT) Stock ForecastsMarch 6, 2025 | ca.finance.yahoo.comFulgent Genetics (NASDAQ:FLGT) Raised to "Hold" at StockNews.comStockNews.com raised shares of Fulgent Genetics from a "sell" rating to a "hold" rating in a report on Wednesday.March 6, 2025 | marketbeat.comInsider Buying: Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Buys 100,000 Shares of StockFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) CFO Paul Kim bought 100,000 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The shares were bought at an average cost of $15.96 per share, with a total value of $1,596,000.00. Following the completion of the purchase, the chief financial officer now directly owns 348,282 shares of the company's stock, valued at $5,558,580.72. This represents a 40.28 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.March 6, 2025 | marketbeat.comPaul Kim Acquires 100,000 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockMarch 6, 2025 | insidertrades.comPiper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock PricePiper Sandler lowered their price objective on Fulgent Genetics from $22.00 to $16.00 and set a "neutral" rating for the company in a research note on Tuesday.March 5, 2025 | marketbeat.comFulgent Genetics price target lowered to $16 from $22 at Piper SandlerMarch 4, 2025 | markets.businessinsider.comFulgent Genetics price target lowered to $20 from $27 at UBSMarch 2, 2025 | markets.businessinsider.com Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address FLGT Media Mentions By Week FLGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FLGT News Sentiment▼0.730.64▲Average Medical News Sentiment FLGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FLGT Articles This Week▼202▲FLGT Articles Average Week Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PGNY News Today ADUS News Today ARDT News Today WGS News Today AGL News Today PACS News Today NHC News Today TDOC News Today GRAL News Today AHCO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FLGT) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGT Stock Free FLGT Stock Alerts